+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Residual mesorectum on postoperative magnetic resonance imaging following transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LapTME) in rectal cancer



Residual mesorectum on postoperative magnetic resonance imaging following transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LapTME) in rectal cancer



Surgical Endoscopy 2018



The standard treatment for mid- and low-rectal cancer is total mesorectal excision. Incomplete excision is an important predictor of local recurrence after rectal cancer surgery. Transanal TME (TaTME) is a new treatment option in which the rectum is approached with both laparoscopic and transanal endoscopic techniques. The aim of the present study was to determine the prevalence and localisation of residual mesorectal tissue by postoperative magnetic resonance imaging (MRI) of the pelvis and compare this between TaTME and laparoscopic TME (LapTME) patients. In addition, we assessed correspondence with histopathological quality. Two groups of patients with cT1-T3 rectal cancer who underwent TME surgery with primary anastomosis were included, each group consisting of 32 patients. Postoperative T2-weighted MRI of the pelvis was performed at least 6 months after TME surgery and evaluated by two radiologists independently. Residual mesorectum was defined as any residual mesorectal tissue detectable after TME. Localisation of the tissue was categorised in relation to height in the pelvis and position of the level of anastomosis. Residual mesorectal tissue was detected in 3.1% of TaTME patients and of 46.9% in LapTME patients (p < 0.001). Multivariate analysis identified only type of surgery as a significant risk factor for leaving residual mesorectum. Other known risk factors for incomplete TME, such as body mass index (BMI) and male gender, were not significant. No relation was seen between specimen quality and prevalence of residual mesorectum. The completeness of mesorectal excision was significantly better with TaTME than with standard laparoscopic technique.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065478572

Download citation: RISBibTeXText

PMID: 29967990

DOI: 10.1007/s00464-018-6279-9


Related references

Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. Bmc Cancer 16: 380, 2017

An Initial Experience Comparing Robotic Total Mesorectal Excision (RTME) and Transanal Total Mesorectal Excision (taTME) for Low Rectal Tumours. Annals of the Academy of Medicine, Singapore 47(5): 188-190, 2018

Laparoscopic Transanal Total Mesorectal Excision (taTME) for Rectal Cancer. Journal of Gastrointestinal Surgery 19(10): 1880-1888, 2016

Transanal Total Mesorectal Excision vs Laparoscopic Total Mesorectal Excision in the Treatment of Low and Middle Rectal Cancer: A Propensity Score Matching Analysis. Diseases of the Colon and Rectum 61(7): 809-816, 2018

Transanal Total Mesorectal Excision in Lower Rectal Cancer: Comparison of Short-Term Outcomes with Conventional Laparoscopic Total Mesorectal Excision. Journal of Laparoendoscopic and Advanced Surgical Techniques. Part a 28(4): 365-369, 2017

Three-Year Nationwide Experience with Transanal Total Mesorectal Excision for Rectal Cancer in the Netherlands: A Propensity Score Matched Comparison with Conventional Laparoscopic Total Mesorectal Excision. Journal of the American College of Surgeons 2019, 2019

Comparison of short- and long-term outcomes between laparoscope-assisted transanal total mesorectal excision and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: a meta-analysis. Zhonghua Wei Chang Wai Ke Za Zhi 21(8): 924-935, 2018

Combined transanal total mesorectal excision (taTME) with laparoscopic instruments and abdominal robotic surgery in rectal cancer. Techniques in Coloproctology 21(3): 233-235, 2017

Transanal total mesorectal excision for low rectal cancer: a case-matched study comparing TaTME versus standard laparoscopic TME. Cancer Management and Research 10: 5239-5245, 2018

Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes. Surgical Endoscopy 2018, 2018

Transanal total mesorectal excision (TaTME) of a low rectal cancer using transanal minimally invasive surgery. Ceylon Medical Journal 62(4): 244-245, 2018

Transanal total mesorectal excision (taTME) for rectal cancer: a training pathway. Surgical Endoscopy 30(9): 4130-4135, 2017

Transanal Total Mesorectal Excision (TaTME) and Quality of Rectal Cancer Surgery: Do we Really Know?. Annals of Surgery 266(6): E88-E89, 2016

Transanal total mesorectal excision (TaTME) for primary rectal cancer : Video article. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 88(10): 863-866, 2017

Outcomes of a Single Surgeon-Based Transanal-Total Mesorectal Excision (TATME) for Rectal Cancer. Journal of Gastrointestinal Cancer 49(4): 455-462, 2017